Cargando…
Occult Hepatitis B: Clinical Viewpoint and Management
Occult HBV infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBsAg-negative patients with or without serologic markers of previous viral exposure. OBI seems to be higher among subjects at high risk for HBV infection and with liver disease. OBI...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603201/ https://www.ncbi.nlm.nih.gov/pubmed/23533738 http://dx.doi.org/10.1155/2013/259148 |
_version_ | 1782263647263784960 |
---|---|
author | Zobeiri, Mehdi |
author_facet | Zobeiri, Mehdi |
author_sort | Zobeiri, Mehdi |
collection | PubMed |
description | Occult HBV infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBsAg-negative patients with or without serologic markers of previous viral exposure. OBI seems to be higher among subjects at high risk for HBV infection and with liver disease. OBI can be both a source of virus contamination in blood and organ donations and the reservoir for full blown hepatitis after reactivation. HBV reactivation depends on viral and host factors but these associations have not been analyzed thoroughly. In OBI, it would be best to prevent HBV reactivation which inhibits the development of hepatitis and subsequent mortality. In diverse cases with insufficient data to recommend routine prophylaxis, early identification of virologic reactivation is essential to start antiviral therapy. For retrieving articles regarding OBI, various databases, including OVID, PubMed, Scopus, and ScienceDirect, were used. |
format | Online Article Text |
id | pubmed-3603201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-36032012013-03-26 Occult Hepatitis B: Clinical Viewpoint and Management Zobeiri, Mehdi Hepat Res Treat Review Article Occult HBV infection (OBI) is defined as HBV DNA detection in serum or in the liver by sensitive diagnostic tests in HBsAg-negative patients with or without serologic markers of previous viral exposure. OBI seems to be higher among subjects at high risk for HBV infection and with liver disease. OBI can be both a source of virus contamination in blood and organ donations and the reservoir for full blown hepatitis after reactivation. HBV reactivation depends on viral and host factors but these associations have not been analyzed thoroughly. In OBI, it would be best to prevent HBV reactivation which inhibits the development of hepatitis and subsequent mortality. In diverse cases with insufficient data to recommend routine prophylaxis, early identification of virologic reactivation is essential to start antiviral therapy. For retrieving articles regarding OBI, various databases, including OVID, PubMed, Scopus, and ScienceDirect, were used. Hindawi Publishing Corporation 2013 2013-03-04 /pmc/articles/PMC3603201/ /pubmed/23533738 http://dx.doi.org/10.1155/2013/259148 Text en Copyright © 2013 Mehdi Zobeiri. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Zobeiri, Mehdi Occult Hepatitis B: Clinical Viewpoint and Management |
title | Occult Hepatitis B: Clinical Viewpoint and Management |
title_full | Occult Hepatitis B: Clinical Viewpoint and Management |
title_fullStr | Occult Hepatitis B: Clinical Viewpoint and Management |
title_full_unstemmed | Occult Hepatitis B: Clinical Viewpoint and Management |
title_short | Occult Hepatitis B: Clinical Viewpoint and Management |
title_sort | occult hepatitis b: clinical viewpoint and management |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603201/ https://www.ncbi.nlm.nih.gov/pubmed/23533738 http://dx.doi.org/10.1155/2013/259148 |
work_keys_str_mv | AT zobeirimehdi occulthepatitisbclinicalviewpointandmanagement |